Titre :
  • A phase II trial with docetaxel (Taxotere) in second line treatment with chemotherapy for advanced breast cancer. A study of the EORTC Early Clinical Trials Group.
Auteur : ten Bokkel Huinink, Wim ; Prove, A M ; Piccart-Gebhart, Martine ; Steward, W ; Tursz, T ; Wanders, Jantien ; Franklin, H ; Clavel, Michel ; Verweij, Jaap ; Alakl, M
Informations sur la publication : Annals of oncology, 5, 6, (page 527-532)
Statut de publication : Publié, 1994-07
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Adult
Aged
Antineoplastic Agents, Phytogenic -- administration & dosage
Antineoplastic Agents, Phytogenic -- adverse effects
Antineoplastic Agents, Phytogenic -- therapeutic use
Breast Neoplasms -- drug therapy
Drug Administration Schedule
Drug Eruptions -- etiology
Europe
Female
Humans
Middle Aged
Nervous System Diseases -- chemically induced
Neutropenia -- chemically induced
Paclitaxel -- administration & dosage
Paclitaxel -- adverse effects
Paclitaxel -- analogs & derivatives
Paclitaxel -- therapeutic use
Remission Induction
Taxoids
Note : Clinical Trial
Clinical Trial, Phase II
Journal Article
Multicenter Study
Langue :
  • Anglais
Identificateurs : urn:issn:0923-7534 
info:pmid/7918124